Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nordlinger

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Gut|November 1, 1995
Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stagesJ A Martinez, S Prevot, B Nordlinger, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trialM Ducreux, E Van Cutsem, J L Van Laethem, et al.
Surgery|May 2, 2001
Survival and functions of encapsulated porcine hepatocytes after allotransplantation or xenotransplantation without immunosuppressionS Benoist, R Sarkis, V Barbu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2014
Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983E Tanis, B Nordlinger, M Mauer, et al.
Annals of Surgery|April 5, 2000
Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trialJ C Vaillant, B Nordlinger, S Deuffic, et al.
The Journal of Clinical Investigation|August 1, 1979
Tyramine kinetics and metabolism in cirrhosisB A Faraj, J T Fulenwider, E B Rypins, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 7, 2013
[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer]E Le Fur, G Chatellier, A Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)O Bouché, M Ychou, P Burtin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2012
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)T Ruers, C Punt, F Van Coevorden, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)E Van Cutsem, M Dicato, J Wils, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Gut|November 1, 1995
Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stagesJ A Martinez, S Prevot, B Nordlinger, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trialM Ducreux, E Van Cutsem, J L Van Laethem, et al.
Surgery|May 2, 2001
Survival and functions of encapsulated porcine hepatocytes after allotransplantation or xenotransplantation without immunosuppressionS Benoist, R Sarkis, V Barbu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2014
Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983E Tanis, B Nordlinger, M Mauer, et al.
Annals of Surgery|April 5, 2000
Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer: A multicenter phase III trialJ C Vaillant, B Nordlinger, S Deuffic, et al.
The Journal of Clinical Investigation|August 1, 1979
Tyramine kinetics and metabolism in cirrhosisB A Faraj, J T Fulenwider, E B Rypins, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 7, 2013
[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer]E Le Fur, G Chatellier, A Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)O Bouché, M Ychou, P Burtin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2012
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)T Ruers, C Punt, F Van Coevorden, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2002
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)E Van Cutsem, M Dicato, J Wils, et al.
Pageof 20